Spyre Therapeutics, Inc.
$79.90
-0.20 (-0.25%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -13.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -27.8%
Own SYRE?
See how SYRE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.